256
SUMMARY
That is a lot of information to digest and I did not include headlines and highlights that I thought were not as important as those above. Every one of these companies has made significant advancements since our August article. Did you notice the dots that are being connected?
QCA has deals with several leading companies including ALEF which is included in this same strategy and case study (ALEF and CMM merged). QCA also has a deal with High Hampton which was our February feature company for good reason. QCA’s record revenues (19 fold increase year over year) cannot be dismissed either and it remains as one of the only companies with a regular dividend. ACB’s CEO Terry Booth is also now on the board. From previous coverage, you also know that QCA is invested in yet another company within this strategy and case study – Canada House Wellness.
ALEF not only has a relationship with QCA but look at their team! Julio Fantino and John Philpot as well as Dr. Michael Verbora. That is just a snapshot and I suggest you look at the rest of the team there. A basic tenet is to invest in the team!
ISOL has too much positive going for it to break it all down succinctly but one piece of news that went un-noticed by most was their deal with Nuuvera … Nuveera of course was recently acquired by Aphria.
Namaste falls in the same complexity as ISOL with too much positive news to deconstruct here. But they have their license from Health Canada now and have supply agreements set up with Supreme Cannabis Company – our last month’s feature company.
When I wrote the original case study in August, I had no knowledge of any of these game changing material events. To have just one of these events happen to just one of these companies only would speak volumes but for all of them and for some to have entered into arrangements with one another once again is your advantage to subscribing. Forward thinking prospective coverage. And the recent bearish market wide sentiment means that you have a second chance now to consider any of these companies for further research. Second chances are so rare no matter when in life.
Until next month – we will be hard at work connecting the dots so you don’t have to.
An August 2017 Case Study Revisited
@Louis. Kyron